D-Allose-13C-2
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


D-Allose-13C-2
Description:
D-Allose-13C-2 is the 13C labeled D-Allose (HY-128741) . D-Allose exhibits antitumor activity against various cancer cells. D-Allose scavenges reactive oxygen species (ROS) and reduces oxidative stress damage. D-Allose exhibits anti-inflammatory and neuroprotective through inhibition of TLR4/PI3K/AKT signaling pathway. D-Allose exhibits antihypertensive, cryoprotective, and anti-osteoporotic activities[1][2][5].UNSPSC:
12352211Target:
Akt; Apoptosis; Endogenous Metabolite; Isotope-Labeled Compounds; PI3K; Reactive Oxygen Species (ROS)Type:
Isotope-Labeled CompoundsRelated Pathways:
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Others; PI3K/Akt/mTORApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular DiseaseAssay Protocol:
https://www.medchemexpress.com/d-allose-13c-2.htmlSolubility:
10 mM in DMSOSmiles:
O=C[C@@H]([C@@H]([13C@@H]([C@@H](CO)O)O)O)OMolecular Formula:
C5 13CH12O6Molecular Weight:
181.15References & Citations:
[1]Chen Z, et al., Recent research on the physiological functions, applications, and biotechnological production of D-allose. Appl Microbiol Biotechnol. 2018 May;102 (10) :4269-4278. |[2]Sui L, et al., Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro. Anticancer Res. 2005 Jul-Aug;25 (4) :2639-44.|[3]Gao D, et al., Anti-inflammatory effect of D-allose in cerebral ischemia/reperfusion injury in rats. Neurol Med Chir (Tokyo) . 2013;53 (6) :365-74.|[4]Akumwami S, et al., Effects of D-Allose on experimental cardiac hypertrophy. J Pharmacol Sci. 2024 Oct;156 (2) :142-148.Shipping Conditions:
Room temperatureScientific Category:
Isotope-Labeled CompoundsClinical Information:
No Development Reported
